- Home
- NARI
NARI
Inari Medical Inc.
as 07-26-2024 4:00pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as Inari Medical Inc. NARI prepares to release earnings report on 30 Jul 2024.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | N/A | IPO Year: | 2020 |
| Target Price: | $66.40 | AVG Volume (30 days): | 787.2K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.41 | EPS Growth: | N/A |
| 52 Week Low/High: | $36.73 - $71.85 | Next Earning Date: | 07-30-2024 |
| Revenue: | $520,659,000 | Revenue Growth: | 26.10% |
| Revenue Growth (this year): | 23.69% | Revenue Growth (next year): | 18.16% |
Stock Insider Trading Activity of Inari Medical Inc. (NARI)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Chambers Rebecca | NARI | Director | Jun 21 '24 | Sell | $45.99 | 260 | $11,957.40 | 9,684 | SEC Form 4 |
| Hill, Mitch C. | NARI | Chief Financial Officer | Jun 12 '24 | Sell | $48.04 | 2,502 | $120,196.08 | 181,294 | SEC Form 4 |
| Hill, Mitch C. | NARI | Chief Financial Officer | Jun 12 '24 | Sell | $47.15 | 2,498 | $117,780.70 | 183,796 | SEC Form 4 |
| Hoffman William | NARI | Director | May 28 '24 | Sell | $50.13 | 60,000 | $3,007,800.00 | 865,359 | SEC Form 4 |
| Hykes Andrew | NARI | President and CEO | May 28 '24 | Sell | $50.00 | 3,000 | $150,000.00 | 465,474 | SEC Form 4 |
| Chambers Rebecca | NARI | Director | May 20 '24 | Sell | $45.39 | 964 | $43,755.96 | 9,944 | SEC Form 4 |
| Hoffman William | NARI | Director | May 16 '24 | Sell | $46.51 | 32,701 | $1,520,923.51 | 932,658 | SEC Form 4 |
| Hoffman William | NARI | Director | May 16 '24 | Sell | $47.00 | 7,299 | $343,053.00 | 925,359 | SEC Form 4 |
| Hill, Mitch C. | NARI | Chief Financial Officer | May 13 '24 | Sell | $44.49 | 300 | $13,347.00 | 186,994 | SEC Form 4 |
| Hill, Mitch C. | NARI | Chief Financial Officer | May 13 '24 | Sell | $45.73 | 3,500 | $160,055.00 | 183,494 | SEC Form 4 |
| Hill, Mitch C. | NARI | Chief Financial Officer | May 13 '24 | Sell | $46.55 | 2,200 | $102,410.00 | 181,294 | SEC Form 4 |
| Hoffman William | NARI | Director | May 1 '24 | Sell | $41.94 | 35,858 | $1,503,884.52 | 968,050 | SEC Form 4 |
| Hoffman William | NARI | Director | May 1 '24 | Sell | $42.73 | 2,491 | $106,440.43 | 965,559 | SEC Form 4 |
| Hoffman William | NARI | Director | May 1 '24 | Sell | $43.61 | 200 | $8,722.00 | 965,359 | SEC Form 4 |
| Hoffman William | NARI | Director | Apr 16 '24 | Sell | $40.00 | 1,451 | $58,040.00 | 999,782 | SEC Form 4 |
| Hill, Mitch C. | NARI | Chief Financial Officer | Apr 12 '24 | Sell | $40.96 | 6,000 | $245,760.00 | 181,294 | SEC Form 4 |
| Hoffman William | NARI | Director | Mar 18 '24 | Sell | $40.98 | 27,492 | $1,126,622.16 | 1,015,804 | SEC Form 4 |
| Hoffman William | NARI | Director | Mar 18 '24 | Sell | $41.45 | 12,508 | $518,456.60 | 1,003,296 | SEC Form 4 |
| Hill, Mitch C. | NARI | Chief Financial Officer | Mar 12 '24 | Sell | $42.58 | 1 | $42.58 | 183,361 | SEC Form 4 |
| Hill, Mitch C. | NARI | Chief Financial Officer | Mar 12 '24 | Sell | $41.91 | 5,999 | $251,418.09 | 183,362 | SEC Form 4 |
| Hoffman William | NARI | Director | Dec 15 '23 | Sell | $64.98 | 11,018 | $715,949.64 | 1,059,475 | SEC Form 4 |
| Hoffman William | NARI | Director | Dec 15 '23 | Sell | $65.38 | 3,982 | $260,343.16 | 1,055,493 | SEC Form 4 |
| Hoffman William | NARI | Director | Dec 15 '23 | Sell | $65.01 | 8,300 | $539,583.00 | 1,047,193 | SEC Form 4 |
| Hoffman William | NARI | Director | Dec 15 '23 | Sell | $65.41 | 1,700 | $111,197.00 | 1,045,493 | SEC Form 4 |
| Hill, Mitch C. | NARI | Chief Financial Officer | Dec 12 '23 | Sell | $62.24 | 2,918 | $181,616.32 | 173,812 | SEC Form 4 |
Latest Inari Medical Inc. News
NARI Breaking Stock News: Dive into NARI Ticker-Specific Updates for Smart Investing
Simply Wall St.
14 hours ago
Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?
MT Newswires
a day ago
William Blair Starts Inari Medical With Outperform Rating
Zacks
2 days ago
Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Argus Research
3 days ago
NARI: Lowering target price to $44.00
Zacks
3 days ago
Inari Medical, Inc. (NARI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
GuruFocus.com
8 days ago
Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI)
GuruFocus.com
8 days ago
Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)
MT Newswires
8 days ago
Inari Medical Insider Sold Shares Worth $3,404,646, According to a Recent SEC Filing
Compare NARI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NARI Inari Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.